Company Filing History:
2 out of 2,668 
2 out of 2,198 Years Active: 2006-2008
Title: Katherine E Kilpatrick: Innovator in Monoclonal Antibody Development
Introduction
Katherine E Kilpatrick is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, her work focuses on innovative therapeutic strategies targeting cancer cells.
Latest Patents
Kilpatrick's latest patents include the invention of EphA2 monoclonal antibodies and methods of making and using them. This invention provides a monoclonal antibody, a fragment thereof, or a molecular complex that binds to an extracellular domain of an EphA2 receptor molecule. The binding of the monoclonal antibody or its fragment to the EphA2 receptor molecule present in the membrane of a cancer cell favorably alters the activity of the EphA2 receptor molecule. The invention further relates to methods of making and using these monoclonal antibodies, fragments, and molecular complexes. The monoclonal antibodies target the extracellular domain of EphA2 and redirect its function to selectively block the growth and invasiveness of metastatic cells. This innovative approach allows for therapeutic strategies that optimally target metastatic cells while minimizing collateral damage to normal tissues.
Career Highlights
Throughout her career, Kilpatrick has worked with reputable organizations such as the Purdue Research Foundation and SmithKline Beecham Corporation. Her experience in these institutions has contributed to her expertise in the field of monoclonal antibody research and development.
Collaborations
Kilpatrick has collaborated with notable individuals in her field, including Michael Scott Kinch and Kelly Carles-Kinch. These collaborations have likely enhanced her research and innovation efforts.
Conclusion
Katherine E Kilpatrick is a pioneering inventor whose work in monoclonal antibodies has the potential to revolutionize cancer treatment. Her innovative approaches and collaborations continue to contribute to advancements in biotechnology.